MOH engaging Great Eastern to better understand suspension of Mount Elizabeth pre-authorisation
GE's rationale was that high costs from the two named hospitals were the reason for this decision. PHOTO: ST FILE
SINGAPORE – The Ministry of Health (MOH) is engaging insurance group Great Eastern (GE) to better understand the impact of its decision to suspend pre-authorisation certificates for the Mount Elizabeth hospitals.
In its reply to queries from the media, MOH said Integrated Shield Plans (IPs) insurers 'would have to ensure that policyholders continue to be able to access the full benefits of their policies in accordance with the terms and conditions for claims, as stated in their policy contracts'.
GE, in a message to its panel doctors earlier this week, said it has temporarily stopped issuing pre-authorisation certificates from June 17 for policyholders admitted to Mount Elizabeth and Mount Elizabeth Novena hospitals.
Its rationale was that high costs from the two named hospitals, compared with other private hospitals, were the reason for this decision.
Pre-authorisation confirms that the insurer has approved the medical treatment, including the costs, before the treatment begins.
GE told its panel doctors the decision was not a reflection of their clinical quality, but the insurer was 'prioritising facilities that deliver the same high-quality care with greater cost transparency and cost-effectiveness'.
The decision took both the hospitals and GE policyholders by surprise.
In its e-mail to the media, MOH said the ability to afford major medical expenses is understandably a concern for Singaporeans and that all Singaporeans are covered by MediShield Life, which is sized to provide coverage for large subsidised bills.
'Singaporeans may opt to purchase IPs or additional coverage. As these are commercial products, while MOH regulates the key parameters of IPs for financial sustainability, individual insurers' changes to administrative processes such as pre-authorisation framework and partnerships with private providers are based on their commercial and actuarial considerations.'
The Straits Times has reached out to both GE and IHH Healthcare , which owns the Mount Elizabeth hospitals.
Join ST's WhatsApp Channel and get the latest news and must-reads.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
2 days ago
- Straits Times
S'poreans can test for genetic condition causing high cholesterol levels under new programme
The new genetic testing programme for familial hypercholesterolaemia comes amid broader efforts to enhance preventive care in Singapore. ST PHOTO: KUA CHEE SIONG S'poreans can test for genetic condition causing high cholesterol levels under new programme SINGAPORE - Eligible Singapore residents will be able to screen for a genetic condition which causes high cholesterol levels at a subsidised rate as part of a nationwide programme launching on June 30. In a statement on June 19, the Ministry of Health (MOH) said that the new genetic testing programme for familial hypercholesterolaemia (FH) comes amid broader efforts to enhance preventive care in Singapore. The initiative aims to identify individuals with FH early and reduce the risk of premature heart disease with timely interventions. FH is a hereditary condition that impacts the body's ability to process cholesterol, affecting roughly 20,000 people in Singapore. People with the condition are up to 20 times more likely to experience heart attacks at a younger age compared with the general population. In a Facebook post on June 19, Health Minister Ong Ye Kung said that the Government is looking to expand preventive care based on genetic testing to more diseases beyond FH. 'It is part of our longer term effort to develop predictive preventive care under Healthier SG,' he said. As part of this effort, the ministry aims to open three genomic assessment centres (GACs) to ensure effective, efficient and sustainable delivery of genetic testing services within each healthcare cluster. Genetics testing for FH at these centres will be subsidised for eligible Singapore citizens and permanent residents (PRs). They can also tap on MediSave to offset the cost. Those referred to GACs will undergo: Pre-test genetic counselling to understand potential outcomes and benefits before consenting to the test Blood drawing and the genetic test Post-test genetic counselling, to understand the implications of the results The first GAC will be operated by SingHealth and located at the National Heart Centre. It will start accepting referrals from June 30. This centre will serve all Singapore residents until additional centres open. GACs operated by National Healthcare Group and National University Health System will subsequently open to cater to residents' needs. Immediate family members of those found with the condition are at risk and encouraged to undergo genetic testing, MOH said. Known as cascade screening, this process enables early detection of FH within families. It also allows for timelier intervention and treatment, such as advising them to adopt healthier lifestyles or starting on cholesterol-lowering therapies. Referral criteria and charges Under the programme, Singapore citizens and PRs with abnormally high cholesterol levels may be referred by their doctors for genetic testing. Eligible Singaporeans and PRs can receive subsidies of up to 70 per cent for the costs, which include the genetic tests, pre-test and post-test counselling, and phlebotomy services . Seniors from the Pioneer Generation and Merdeka Generation are also eligible for additional subsidies. After subsidies, referred patients can expect to pay between $117 and $575 . Those eligible for cascade screening can expect to pay between $53 and $253 after subsidies. The MediSave500 and MediSave700 scheme can be used to further offset the cost of the genetic test after subsidies. Patients who are 60 years old and above may also use Flexi-MediSave to further defray out of pocket costs. Protection of genetic information Under a moratorium on genetic testing and insurance introduced by MOH and the Life Insurance Association Singapore (LIA) in 2021, life insurers here are banned from using predictive genetic test results in assessing the outcome of insurance applications, unless certain criteria are satisfied. Insurers are also not allowed to use genetic test results from biomedical research or direct-to-consumer genetic test results. MOH said it has worked with the LIA to amend the moratorium t o disallow life insurers in Singapore to use the results of all genetic tests conducted under the national FH genetic testing programme. They may, however, continue to request for individuals to disclose existing diagnosed conditions and family history. The amended moratorium will take effect from June 30. Join ST's WhatsApp Channel and get the latest news and must-reads.
CNA
2 days ago
- CNA
Singapore launches national genetic testing programme for inherited cholesterol condition
SINGAPORE: Singapore will on Jun 30 start a national genetic testing programme for an inherited cholesterol condition, the Ministry of Health (MOH) said on Thursday (Jun 19). The programme aims to identify individuals with familial hypercholesterolaemia (FH) early and reduce the risk of premature heart disease for these individuals with timely interventions. An estimated 20,000 people in Singapore have FH, a condition that affects the body's ability to process cholesterol. People with FH face a "significantly higher risk" – up to 20 times more – of experiencing heart attacks at a younger age compared with the general population. It is a hereditary condition. MOH plans to open three Genomic Assessment Centres (GAC) within each of the three healthcare clusters. The first, operated by SingHealth, will be located at the National Heart Centre. It will start accepting referrals from Jun 30. Two other centres, operated by the National Healthcare Group and National University Health System, will be opened subsequently. Individuals referred to these centres will undergo pre-test genetic counselling to understand potential outcomes and benefits before the test, the drawing of blood and the test. They will also get post-test genetic counselling to understand the implications of the results. WHO QUALIFIES? Singaporeans and permanent residents with "abnormally high" cholesterol levels may be referred by their doctors to the GAC for FH genetic testing. Abnormally high levels refer to LDL-C levels of more than or equal to 5.5mmol/L or 212mg/dL. If a person tests positive for FH, their immediate family members – parents, siblings and children – will be at risk and are encouraged to undergo genetic testing. This process is known as cascade screening and enables early detection of FH within families. "In turn, it allows for timelier intervention and treatment, such as advising them to adopt healthier lifestyles and starting them on cholesterol-lowering therapies, if necessary, to reduce their risk of premature heart disease," said MOH. In a Facebook post on Thursday, Health Minister Ong Ye Kung said: "We want to expand preventive care based on genetic testing to more diseases, beyond FH. "It is part of our longer-term effort to develop predictive preventive care under Healthier SG." HOW MUCH WILL IT COST? The costs for FH genetic testing include the drawing of blood, tests, as well as pre-test and post-test counselling. At the GACs, eligible Singaporeans and permanent residents can get means-tested subsidies of up to 70 per cent for these costs. Seniors from the Pioneer Generation and Merdeka Generation are eligible for additional subsidies. After subsidies, patients who are referred to do FH testing can expect to pay between S$117 (US$91) and S$575. Eligible immediate family members of those who have tested positive for FH can expect to pay between S$53 and S$253 after subsidies. MediSave500/700 can be used to further offset the cost of the genetic test after subsidies. Patients who are 60 and above may also use Flexi-MediSave to further defray out-of-pocket costs. Most patients who test positive for FH will require a combination of medication and lifestyle modifications, such as dietary changes and physical activity, to achieve a healthy cholesterol level and prevent premature heart disease, MOH said. "Patients are advised to follow up with a primary care provider at the polyclinics or general practitioner (GP) clinics, or with their family doctor if they are enrolled in Healthier SG for continued management. Subsidies are available for selected chronic medications," it added. INSURANCE A moratorium on genetic testing and insurance was introduced by MOH and the Life Insurance Association Singapore (LIA) in October 2021. Under this agreement, life insurers in Singapore are not allowed to use predictive genetic test results in assessing or deciding the outcome of insurance applications, unless certain criteria are satisfied. Insurers are also not allowed to use genetic test results from biomedical research or direct-to-consumer genetic test results MOH has worked with the LIA to amend the moratorium to disallow life insurers in Singapore from using the results of all genetic tests - both predictive and diagnostic - conducted under the national FH genetic testing programme. "As with standard insurance underwriting practice, they may however request individuals to disclose existing diagnosed conditions (including FH) and family history.
Straits Times
2 days ago
- Straits Times
MOH engaging Great Eastern to better understand suspension of Mount Elizabeth pre-authorisation
GE's rationale was that high costs from the two named hospitals were the reason for this decision. PHOTO: ST FILE SINGAPORE – The Ministry of Health (MOH) is engaging insurance group Great Eastern (GE) to better understand the impact of its decision to suspend pre-authorisation certificates for the Mount Elizabeth hospitals. In its reply to queries from the media, MOH said Integrated Shield Plans (IPs) insurers 'would have to ensure that policyholders continue to be able to access the full benefits of their policies in accordance with the terms and conditions for claims, as stated in their policy contracts'. GE, in a message to its panel doctors earlier this week, said it has temporarily stopped issuing pre-authorisation certificates from June 17 for policyholders admitted to Mount Elizabeth and Mount Elizabeth Novena hospitals. Its rationale was that high costs from the two named hospitals, compared with other private hospitals, were the reason for this decision. Pre-authorisation confirms that the insurer has approved the medical treatment, including the costs, before the treatment begins. GE told its panel doctors the decision was not a reflection of their clinical quality, but the insurer was 'prioritising facilities that deliver the same high-quality care with greater cost transparency and cost-effectiveness'. The decision took both the hospitals and GE policyholders by surprise. In its e-mail to the media, MOH said the ability to afford major medical expenses is understandably a concern for Singaporeans and that all Singaporeans are covered by MediShield Life, which is sized to provide coverage for large subsidised bills. 'Singaporeans may opt to purchase IPs or additional coverage. As these are commercial products, while MOH regulates the key parameters of IPs for financial sustainability, individual insurers' changes to administrative processes such as pre-authorisation framework and partnerships with private providers are based on their commercial and actuarial considerations.' The Straits Times has reached out to both GE and IHH Healthcare , which owns the Mount Elizabeth hospitals. Join ST's WhatsApp Channel and get the latest news and must-reads.
